Patents/Assignees

ARBUTUS BIOPHARMA CORPORATION

18 patents in portfolio

US12453776utility2025
Lipids and Compositions for the Delivery of Therapeutics
0 cites
US12357705utility2025
Negatively Charged Peg-lipid Conjugates
0 cites
US12350383utility2025
Cationic Lipids Containing Silicon
0 cites
US12251470utility2025
Lipid Nanoparticle Formulations
0 cites
US12129467utility2024
Non-liposomal Systems for Nucleic Acid Delivery
0 cites
US12083118utility2024
Substituted 1,1′-biphenyl Compounds, Analogues Thereof, and Methods Using Same
0 cites
US12042541utility2024
Lipids and Compositions for the Delivery of Therapeutics
0 cites
US12043833utility2024
Targeted Compositions
0 cites
US12037587utility2024
Non-liposomal Systems for Nucleic Acid Delivery
0 cites
US12023383utility2024
Lipid Compositions
0 cites
US12016929utility2024
Lipid Formulations for Delivery of Therapeutic Agents
0 cites
US11904052utility2024
Methods for Ameliorating Infusion Reactions
0 cites
US11896672utility2024
Targeted Nucleic Acid Conjugate Compositions
0 cites
US11786598utility2023
Lipid Formulations for Delivery of Therapeutic Agents
0 cites
US11718852utility2023
Non-liposomal Systems for Nucleic Acid Delivery
0 cites
US11712476utility2023
Lipids and Compositions for the Delivery of Therapeutics
0 cites
US11702427utility2023
Substituted 2-pyridone Tricyclic Compounds, Analogues Thereof, and Methods Using Same
0 cites
US11566002utility2023
Substituted Tetrahydrocyclopenta[c]pyrroles, Substituted Dihydropyrrolizines, Analogues Thereof, and Methods Using Same
0 cites